OpenURL Connection Search

Select item for more details and to access through your institution.

C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12058-y
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Shimada, Noritomo;
- Kawata, Kazuhito
Publication type:
Article
Reactivation of hepatitis B virus in patients with undetectable HBsAg undergoing chemotherapy for malignant lymphoma or multiple myeloma.
Published in:
Journal of Medical Virology, 2013, v. 85, n. 11, p. 1900, doi. 10.1002/jmv.23694
By:
- Matsui, Takeshi;
- Kang, Jong‐Hon;
- Nojima, Masanori;
- Tomonari, Akiko;
- Aoki, Hironori;
- Yamazaki, Hajime;
- Yane, Kei;
- Tsuji, Kunihiko;
- Andoh, Seisho;
- Andoh, Sachiko;
- Sakai, Hajime;
- Maemori, Masayo;
- Maguchi, Hiroyuki;
- Tanaka, Yasuhito
Publication type:
Article
Utility of serological tumor biomarkers for surveillance of hepatocellular carcinoma in patients undergoing dialysis.
Published in:
Nephrology Dialysis Transplantation, 2021, v. 36, n. 6, p. 1097, doi. 10.1093/ndt/gfaa165
By:
- Toyoda, Hidenori;
- Kikuchi, Kan;
- Tsuruta, Yuki;
- Hiraoka, Atsushi;
- Tsuji, Kunihiko;
- Tanaka, Junko
Publication type:
Article
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
Published in:
Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2042
By:
- Ohama, Hideko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Hatanaka, Takeshi;
- Tani, Joji;
- Takaguchi, Koichi;
- Atsukawa, Masanori;
- Itobayashi, Ei;
- Nishimura, Takashi;
- Tsuji, Kunihiko;
- Tajiri, Kazuto;
- Ishikawa, Toru;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Fukunishi, Shinya;
- Ogawa, Chikara;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience.
Published in:
Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1464
By:
- Atsushi Hiraoka;
- Takashi Kumada;
- Toshifumi Tada;
- Masashi Hirooka;
- Kazuya Kariyama;
- Joji Tani;
- Masanori Atsukawa;
- Koichi Takaguchi;
- Ei Itobayashi;
- Shinya Fukunishi;
- Kunihiko Tsuji;
- Toru Ishikawa;
- Kazuto Tajiri;
- Hironori Ochi;
- Satoshi Yasuda;
- Hidenori Toyoda;
- Chikara Ogawa;
- Takashi Nishimura;
- Takeshi Hatanaka;
- Hideko Ohama
Publication type:
Article
ORIGINAL ARTICLE Efficacy and long-term outcome of laparoscopic microwave coagulation or radiofrequency ablation therapy for surface-type hepatocellular carcinoma.
Published in:
Digestive Endoscopy, 2004, v. 16, n. 2, p. 117, doi. 10.1111/j.1443-1661.2003.00323.x
By:
- Tsuji, Kunihiko;
- Nishimori, Hiroyuki;
- Sakurai, Yasuo;
- Mitsui, Shinya;
- Miyamoto, Noriyuki;
- Matsunaga, Takahiro;
- Kang, Jong-Hon;
- Maguchi, Hiroyuki;
- Maekubo, Hiroshi
Publication type:
Article
Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.
Published in:
Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishikawa, Hiroki;
- Nishimura, Takashi;
- Kawata, Kazuhito;
- Kosaka, Hisashi
Publication type:
Article
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.
Published in:
Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Nishikawa, Hiroki;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Koshiyama, Yuichi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Kawata, Kazuhito
Publication type:
Article
Improved survival of viral hepatocellular carcinoma but not non‐viral hepatocellular carcinoma from 2000 to 2020: A multi‐centre cohort study of 6007 patients from high‐volume academic centres in Japan.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 694, doi. 10.1111/apt.17088
By:
- Toyoda, Hidenori;
- Kariyama, Kazuya;
- Hiraoka, Atsushi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Hatanaka, Takeshi;
- Naganuma, Atsushi;
- Yasuda, Satoshi;
- Nouso, Kazuhiro;
- Kakizaki, Satoru;
- Kumada, Takashi;
- Innes, Hamish;
- Johnson, Philip J.
Publication type:
Article
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
Published in:
Digestive Diseases, 2017, v. 35, n. 6, p. 602, doi. 10.1159/000480256
By:
- Atsushi Hiraoka;
- Takashi Kumada;
- Masatoshi Kudo;
- Masashi Hirooka;
- Yohei Koizumi;
- Yoichi Hiasa;
- Kazuto Tajiri;
- Hidenori Toyoda;
- Toshifumi Tada;
- Hironori Ochi;
- Koji Joko;
- Noritomo Shimada;
- Akihiro Deguchi;
- Toru Ishikawa;
- Michitaka Imai;
- Kunihiko Tsuji;
- Kojiro Michitaka
Publication type:
Article
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
Published in:
Hepatology Research, 2024, v. 54, n. 4, p. 382, doi. 10.1111/hepr.13991
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Yokohama, Keisuke;
- Nishikawa, Hiroki
Publication type:
Article
Geriatric nutritional risk index as an easy‐to‐use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Published in:
Hepatology Research, 2023, v. 53, n. 10, p. 1031, doi. 10.1111/hepr.13934
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Association of proton pump inhibitor and antibiotic use with the clinical outcomes of hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: A multicenter analysis.
Published in:
Hepatology Research, 2023, v. 53, n. 8, p. 737, doi. 10.1111/hepr.13905
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
Validation of the easy‐to‐use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib.
Published in:
Hepatology Research, 2022, v. 52, n. 12, p. 1050, doi. 10.1111/hepr.13824
By:
- Rimini, Margherita;
- Kang, Wonseok;
- Burgio, Valentina;
- Persano, Mara;
- Aoki, Tamoko;
- Shimose, Shigeo;
- Tada, Toshifumi;
- Kumada, Takashi;
- Sho, Takuya;
- Lai, Eleonora;
- Celsa, Ciro;
- Campani, Claudia;
- Tonnini, Matteo;
- Tamburini, Emiliano;
- Hiraoka, Atsushi;
- Takaguchi, Koichi;
- Nishida, Naoshi;
- Iwamoto, Hideki;
- Itobayashi, Ei;
- Tsuji, Kunihiko
Publication type:
Article
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice.
Published in:
Hepatology Research, 2022, v. 52, n. 9, p. 773, doi. 10.1111/hepr.13797
By:
- Tanaka, Takaaki;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis.
Published in:
Hepatology Research, 2022, v. 52, n. 5, p. 462, doi. 10.1111/hepr.13748
By:
- Hatanaka, Takeshi;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis.
Published in:
Hepatology Research, 2022, v. 52, n. 3, p. 308, doi. 10.1111/hepr.13734
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression.
Published in:
Hepatology Research, 2021, v. 51, n. 8, p. 880, doi. 10.1111/hepr.13644
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Hatanaka, Takeshi;
- Tada, Toshifumi;
- Kariyama, Kazuya;
- Tani, Joji;
- Fukunishi, Shinya;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Kawata, Kazuhito;
- Yasuda, Satoshi;
- Toyoda, Hidenori
Publication type:
Article
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.
Published in:
Hepatology Research, 2020, v. 50, n. 1, p. 75, doi. 10.1111/hepr.13427
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Michitaka, Kojiro;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Tsutsui, Akemi;
- Nagano, Takuya;
- Itokawa, Norio
Publication type:
Article
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis.
Published in:
Hepatology Research, 2019, v. 49, n. 1, p. 111, doi. 10.1111/hepr.13243
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Kariyama, Kazuya;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Shimada, Noritomo;
- Tajiri, Kazuto;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Ochi, Hironori;
- Hirooka, Masashi;
- Tsutsui, Akemi;
- Shibata, Hiroshi;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Joko, Kouji;
- Hiasa, Yoichi;
- Michitaka, Kojiro
Publication type:
Article
A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin–bilirubin grade.
Published in:
Hepatology Research, 2018, v. 48, n. 3, p. E61, doi. 10.1111/hepr.12927
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Itobayashi, Ei;
- Kariyama, Kazuya;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hirofumi;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Joko, Koji;
- Kawasaki, Hideki;
- Hiasa, Yoichi;
- Michitaka, Kojiro;
- On Behalf Of The Real‐life Practice Experts For Hcc (relpec) Study Group And Hcc 48 Group (hepatocellular Carcinoma Experts From 48 Clinics)
Publication type:
Article
Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis C after the eradication of hepatitis C virus: A multicenter study from Japan.
Published in:
Hepatology Research, 2016, v. 46, n. 8, p. 734, doi. 10.1111/hepr.12613
By:
- Toyoda, Hidenori;
- Tada, Toshifumi;
- Tsuji, Kunihiko;
- Hiraoka, Atsushi;
- Tachi, Yoshihiko;
- Itobayashi, Ei;
- Takaguchi, Koichi;
- Senoh, Tomonori;
- Takizawa, Daichi;
- Ishikawa, Toru;
- Kumada, Takashi
Publication type:
Article
Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with Child-Pugh C liver cirrhosis?: A multicenter study.
Published in:
Hepatology Research, 2016, v. 46, n. 6, p. 521, doi. 10.1111/hepr.12583
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Michitaka, Kojiro;
- Toyoda, Hidenori;
- Tada, Toshifumi;
- Ishikawa, Toru;
- Itobayashi, Ei;
- Shimada, Noritomo;
- Takaguchi, Koichi;
- Takizawa, Daichi;
- Tsuji, Kunihiko
Publication type:
Article
Is drug-eluting bead transcatheter arterial chemoembolization (TACE) associated with better tumor response than conventional TACE in meta-analysis?
Published in:
Hepatology Research, 2015, v. 45, n. 12, p. 1258, doi. 10.1111/hepr.12485
By:
- Kodama, Yoshihisa;
- Matsui, Takeshi;
- Tsuji, Kunihiko;
- Sakurai, Yasuo;
- Kang, Jong‐Hon;
- Nagai, Kazumasa;
- Tanaka, Kazunari;
- Tomonari, Akiko;
- Maguchi, Hiroyuki
Publication type:
Article
Rare case of transfusion-transmitted hepatitis E from the blood of a donor infected with the hepatitis E virus genotype 3 indigenous to Japan: Viral dynamics from onset to recovery.
Published in:
Hepatology Research, 2015, v. 45, n. 6, p. 698, doi. 10.1111/hepr.12390
By:
- Matsui, Takeshi;
- Kang, Jong‐Hon;
- Matsubayashi, Keiji;
- Yamazaki, Hajime;
- Nagai, Kazumasa;
- Sakata, Hidekatsu;
- Tsuji, Kunihiko;
- Maguchi, Hiroyuki
Publication type:
Article
Efficacy and long-term outcomes of radiofrequency ablation in the elderly with hepatocellular carcinoma.
Published in:
Hepatology Research, 2014, v. 44, n. 11, p. 1095, doi. 10.1111/hepr.12233
By:
- Yamazaki, Hajime;
- Tsuji, Kunihiko;
- Nagai, Kazumasa;
- Tomonari, Akiko;
- Matsui, Takeshi;
- Kang, Jong‐Hon;
- Kodama, Yoshihisa;
- Sakurai, Yasuo;
- Maguchi, Hiroyuki
Publication type:
Article
Feasibility of the virtual needle tracking system for percutaneous radiofrequency ablation of hepatocellular carcinoma.
Published in:
Hepatology Research, 2013, v. 43, n. 12, p. 1352, doi. 10.1111/hepr.12096
By:
- Tomonari, Akiko;
- Tsuji, Kunihiko;
- Yamazaki, Hajime;
- Aoki, Hironori;
- Kang, Jong‐Hon;
- Kodama, Yoshihisa;
- Sakurai, Yasuo;
- Maguchi, Hiroyuki
Publication type:
Article
Feasibility of fused imaging for the evaluation of radiofrequency ablative margin for hepatocellular carcinoma.
Published in:
Hepatology Research, 2013, v. 43, n. 7, p. 728, doi. 10.1111/hepr.12022
By:
- Tomonari, Akiko;
- Tsuji, Kunihiko;
- Yamazaki, Hajime;
- Aoki, Hironori;
- Kang, Jong‐Hon;
- Kodama, Yoshihisa;
- Sakurai, Yasuo;
- Maguchi, Hiroyuki
Publication type:
Article
Three cases of acute or fulminant hepatitis E caused by ingestion of pork meat and entrails in Hokkaido, Japan: Zoonotic food-borne transmission of hepatitis E virus and public health concerns.
Published in:
Hepatology Research, 2012, v. 42, n. 9, p. 870, doi. 10.1111/j.1872-034X.2012.01006.x
By:
- Miyashita, Kencho;
- Kang, Jong-Hon;
- Saga, Akiyoshi;
- Takahashi, Kazuaki;
- Shimamura, Tsuyoshi;
- Yasumoto, Atsushi;
- Fukushima, Hiraku;
- Sogabe, Susumu;
- Konishi, Kouhei;
- Uchida, Takumi;
- Fujinaga, Akira;
- Matsui, Takeshi;
- Sakurai, Yasuo;
- Tsuji, Kunihiko;
- Maguchi, Hiroyuki;
- Taniguchi, Masahiko;
- Abe, Natsumi;
- Fazle Akbar, Sheikh Mohammad;
- Arai, Masahiro;
- Mishiro, Shunji
Publication type:
Article
Endoscopic thermal ablation therapies for hepatocellular carcinoma: a multi-center study.
Published in:
Hepatology Research, 2009, v. 39, n. 1, p. 47, doi. 10.1111/j.1872-034X.2008.00410.x
By:
- Sakaguchi, Hiroki;
- Seki, Shuichi;
- Tsuji, Kunihiko;
- Teramoto, Kenichi;
- Suzuki, Masatoshi;
- Kioka, Kiyohide;
- Isoda, Norio;
- Ido, Kenichi
Publication type:
Article
Integrated Predictors by Propensity Scoring With Tumor Markers and Plasma Levels of microRNA-21-5p, IL-17, and IL-10 Complement Early Detection of Hepatocellular Carcinoma in Patients With Liver Cirrhosis.
Published in:
Technology in Cancer Research & Treatment, 2023, p. 1, doi. 10.1177/15330338231212084
By:
- Machida, Maiko;
- Ambo, Mayuko;
- Mishina, Runa;
- Hada, Nanaka;
- Tachibana, Fuhito;
- Yamashita, Miki;
- Konda, Ainari;
- Tsuji, Kunihiko
Publication type:
Article
Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.
Published in:
Cancers, 2023, v. 15, n. 17, p. 4348, doi. 10.3390/cancers15174348
By:
- Tanaka, Kazunari;
- Tsuji, Kunihiko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article
Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma.
Published in:
Cancers, 2019, v. 11, n. 2, p. 203, doi. 10.3390/cancers11020203
By:
- Kariyama, Kazuya;
- Nouso, Kazuhiro;
- Toyoda, Hidenori;
- Tada, Toshifumi;
- Hiraoka, Atsushi;
- Tsuji, Kunihiko;
- Itobayashi, Ei;
- Ishikawa, Toru;
- Wakuta, Akiko;
- Oonishi, Ayano;
- Kumada, Takashi;
- Kudo, Masatoshi
Publication type:
Article
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate‐stage hepatocellular carcinoma.
Published in:
Liver International, 2024, v. 44, n. 1, p. 113, doi. 10.1111/liv.15753
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
Published in:
Liver International, 2020, v. 40, n. 4, p. 968, doi. 10.1111/liv.14405
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Michitaka, Kojiro;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Fukunishi, Shinya;
- Ohama, Hideko;
- Kawata, Kazuhito
Publication type:
Article
Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead‐time bias.
Published in:
Liver International, 2018, v. 38, n. 12, p. 2260, doi. 10.1111/liv.13927
By:
- Toyoda, Hidenori;
- Kumada, Takashi;
- Tada, Toshifumi;
- Mizuno, Kazuyuki;
- Hiraoka, Atsushi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Akita, Tomoyuki;
- Tanaka, Junko
Publication type:
Article
Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 565, doi. 10.1159/000530078
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Kariyama, Kazuya;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Naganuma, Atsushi;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Ohama, Hideko;
- Tada, Fujimasa;
- Nouso, Kazuhiro
Publication type:
Article
Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355
By:
- Atsushi Hiraoka;
- Takashi Kumada;
- Toshifumi Tada;
- Kazuya Kariyama;
- Joji Tani;
- Shinya Fukunishi;
- Masanori Atsukawa;
- Masashi Hirooka;
- Kunihiko Tsuji;
- Toru Ishikawa;
- Koichi Takaguchi;
- Ei Itobayashi;
- Kazuto Tajiri;
- Noritomo Shimada;
- Hiroshi Shibata;
- Hironori Ochi;
- Kazuhito Kawata;
- Satoshi Yasuda;
- Hidenori Toyoda;
- Hideko Ohama
Publication type:
Article
EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis.
Published in:
Liver Cancer (2235-1795), 2020, v. 9, n. 6, p. 734, doi. 10.1159/000508971
By:
- Kariyama, Kazuya;
- Nouso, Kazuhiro;
- Hiraoka, Atsushi;
- Wakuta, Akiko;
- Oonishi, Ayano;
- Kuzuya, Teiji;
- Toyoda, Hidenori;
- Tada, Toshifumi;
- Tsuji, Kunihiko;
- Itobayashi, Ei;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Tsutsui, Akemi;
- Shimada, Noritomo;
- Kudo, Masatoshi;
- Kumada, Takashi
Publication type:
Article
Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach.
Published in:
Cancer Medicine, 2023, v. 12, n. 24, p. 21680, doi. 10.1002/cam4.6726
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Yokohama, Keisuke;
- Nishikawa, Hiroki
Publication type:
Article
Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab.
Published in:
Cancer Medicine, 2023, v. 12, n. 17, p. 17849, doi. 10.1002/cam4.6416
By:
- Nouso, Kazuhiro;
- Shiota, Shohei;
- Fujita, Rio;
- Wakuta, Akiko;
- Kariyama, Kazuya;
- Hiraoka, Atsushi;
- Atsukawa, Masanori;
- Tani, Joji;
- Tada, Toshifumi;
- Nakamura, Shinichiro;
- Tajiri, Kazuto;
- Kaibori, Masaki;
- Hirooka, Masashi;
- Itobayashi, Ei;
- Kakizaki, Satoru;
- Naganuma, Atsushi;
- Ishikawa, Toru;
- Hatanaka, Takeshi;
- Fukunishi, Shinya;
- Tsuji, Kunihiko
Publication type:
Article
Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Published in:
Cancer Medicine, 2023, v. 12, n. 7, p. 7772, doi. 10.1002/cam4.5535
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study.
Published in:
Cancer Medicine, 2023, v. 12, n. 6, p. 6980, doi. 10.1002/cam4.5495
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Kariyama, Kazuya;
- Tani, Joji;
- Hirooka, Masashi;
- Takaguchi, Koichi;
- Atsukawa, Masanori;
- Fukunishi, Shinya;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Ishikawa, Toru;
- Yasuda, Satoshi;
- Ogawa, Chikara;
- Toyoda, Hidenori;
- Hatanaka, Takeshi;
- Nishimura, Takashi;
- Kakizaki, Satoru
Publication type:
Article
Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study.
Published in:
Cancer Medicine, 2023, v. 12, n. 5, p. 5293, doi. 10.1002/cam4.5337
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC‐GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis.
Published in:
Cancer Medicine, 2023, v. 12, n. 4, p. 4259, doi. 10.1002/cam4.5294
By:
- Hatanaka, Takeshi;
- Naganuma, Atsushi;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
The prognosis of elderly patients with hepatocellular carcinoma: A multi‐center 19‐year experience in Japan.
Published in:
Cancer Medicine, 2023, v. 12, n. 1, p. 345, doi. 10.1002/cam4.4850
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Kariyama, Kazuya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Toyoda, Hidenori;
- Yasuda, Satoshi;
- Naganuma, Atsushi;
- Tada, Toshifumi;
- Takaguchi, Koichi;
- Tsutsui, Akemi;
- Itobayashi, Ei;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Tanaka, Takaaki;
- Nagano, Takuya;
- Imai, Michitaka;
- Nakamura, Shinichiro;
- Nouso, Kazuhiro
Publication type:
Article
Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib.
Published in:
Cancer Medicine, 2023, v. 12, n. 1, p. 325, doi. 10.1002/cam4.4854
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis.
Published in:
Cancer Medicine, 2022, v. 11, n. 20, p. 3796, doi. 10.1002/cam4.4763
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.
Published in:
Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Tsutsui, Akemi;
- Nagano, Takuya;
- Itokawa, Norio;
- Hayama, Korenobu
Publication type:
Article

Found: 92